Gingipains as a virulence factor in the oral cavity  by Campos Lopes, Pedro et al.
r e v p o r t e s t o m a t o l m e d d e n t c i r m a x i l o f a c . 2 0 1 2;5  3(4):240–245
Revista Portuguesa de Estomatologia,
Medicina Dentária e Cirurgia Maxilofacial
w ww.elsev ier .p t /spemdInvestigation
Gingipains  as  a virulence  factor  in the  oral  cavity
Pedro Campos Lopes, Marlene Barros, Maria José Correia ∗
Departamento de Ciências da Saúde, Universidade Católica Portuguesa, Centro Regional das Beiras, Viseu, Portugal
a  r  t  i  c  l  e  i  n  f  o
Article history:
Received 4 August 2011
Accepted 16 July 2012
Available online 27 September 2012
Keywords:
Porphyromonas gingivalis
Proteases
Periodontitis
Bioinformatics
Elastase
a  b  s  t  r  a  c  t
Aim: The objective of this study is to demonstrate the molecular action of Porphyromonas
gingivalis cysteine proteases such as gingipains (R1, R2 and K) upon human molecules.
Materials and methods: Using the information on protein structure and function available
in  international databases (UniProtKB and Merops Database), the molecular interactions
already described between gingipains and host molecules were clariﬁed.
Results: Possible cleavage sites were identiﬁed in host-produced elastase inhibitors and in
pro-Matrix MetalloProteinase (MMP)1. Analysis of the results leads to the suggestion that the
elastase inhibitor alpha1-antitrypsin is also degraded by interpain A, a cystein protease of
Prevotella intermedia sharing a high homology with the PrtT and periodontain of P. gingivalis.
Conclusion: The information obtained suggests a synergistic molecular mechanism by which
cysteine proteases of different bacteria can be responsible for the clinical manifestations
of  periodontal disease, and illustrates the use of bioinformatics to establish and predict
molecular mechanisms.
© 2011 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Published by
Elsevier España, S.L. All rights reserved.
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Objetivo: O objetivo deste trabalho é veriﬁcar o detalhe molecular da ac¸ão de proteases
de cisteína de Porphyromonas gingivalis como as gingipains (R1, R2 e K) em moléculas do
hospedeiro.
Material e métodos: Utilizando a informac¸ão disponível sobre estrutura e func¸ão de proteínas
nas bases de dados internacionais (UniProtKB e Merops Database) as interac¸ões já descritas
entre gingipains e moléculas do hospedeiro são clariﬁcadas.Resultados: São identiﬁcados possíveis locais de corte das gingipains em inibidores naturais
das  elastases e a identiﬁcac¸ão molecular de um local de corte na pro MetaloProteinase da
Matriz (MMP) 1. A análise dos resultados sugere que a interpain A, uma  protease de cisteína
de  Prevotella intermedia com elevada homologia estrutural com as proteases de cisteína PrtT
e  periodontain de P. gingivalis, também degrada o inibidor de elastases, alfa1antitripsina.
∗ Corresponding author.
E-mail address: mariacorrei@gmail.com (M.J. Correia).
1646-2890/$ – see front matter © 2011 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Published by Elsevier España, S.L. All rights reserved.
http://dx.doi.org/10.1016/j.rpemd.2012.07.002
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Conclusão: Com a integrac¸ão da informac¸ão obtida, sugere-se um possível mecanismo molec-
ular da sinergia criada entre proteinases de cisteína no sentido de promover a doenc¸a
periodontal. Este estudo ilustra a forma como as ferramentas bioinformáticas podem ser
úteis no esclarecimento dos mecanismos moleculares e na previsão de resultados experi-
mentais, melhorando o desenho de estudos laboratoriais.
© 2011 Sociedade Portuguesa de Estomatologia e Medicina Dentária. Publicado por Elsevier
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eriodontitis is an inﬂammatory and infectious disease affect-
ng the supporting tissues of the tooth. Despite the fact that
he microﬂora associated with periodontal disease has been
xtensively studied,1 no species by itself could be identi-
ed as the etiologic agent.2 P. gingivalis has been identiﬁed
s one of the major organisms associated with destructive
dult periodontitis. The virulence of this microorganism is
articularly related to its proteolytic activity, and the cys-
eine peptidases gingipains have been extensively studied and
haracterized.3,4 Gingipains have been described and studied
s being particularly efﬁcient and versatile enzymes, capa-
le of proteolysis of several host molecules associated with
hysiological processes such as host immune defense, cell
dhesion and vascular permeability.5–9 Studies demonstrat-
ng the “in vitro” cleavage of host molecules by gingipains
ften just report a digestion10 and sometimes identify the
esulting fragments either by size11 or by antibody5 based
echniques, but lack information on the molecular details
f the interaction between the gingipains and the host
olecules.
Public databases accumulate an enormous quantity of
equences and structural data and several bioinformatics
ools have been developed. Some of the tools are inte-
rated in the databases and repositories (e.g. Blast search
nd ClustalW2 alignment algorithms) while others are devel-
ped independently such as PyMol.12,13 In either case, the
bjective is the same: to extract biological signiﬁcance
f the accumulated data. This knowledge may then be
sed to direct further scientiﬁc research prompting new
xperimental studies or, in other instances, be applied
n the development of chairside innovative tools and/or
rocedures.
The purpose of this work is to show how the structural
nformation available in public databases such as UniProtKB14
an be explored with bioinformatics tools such as PyMol12
nd Psipred13 to produce information on the interactions
etween host molecules and gingipains. This analysis clari-
es the molecular detail of these interactions and proposes
ew experimental approaches to elucidate other interac-
ions between microbial proteases and host molecules. The
nowledge of the molecular interactions is fundamental not
nly in the development of speciﬁc inhibitors for the action
f gingipains and other microbial proteases,15 but also in
he development of additional diagnostic tools such as the
16ecently described by Kaman et al., and therefore provides a
asis for improvement and innovation in the development of
ew therapeutic approaches and accurate diagnosis of peri-
dontal diseases.España, S.L. Todos os direitos reservados.
Materials  and  methods
The bioinformatics analysis of the interactions between the
gingipains and host molecules was performed using freeware
tools and information available in international databases.
This study focused on host molecules whose interaction was
described in the literature7 and for which crystallographic
structures were available. Because the modeling of mem-
brane proteins still has limitations, we  used only molecules
which are soluble and not integrated in the membrane. To
analyze the interactions the steps followed are described
below.
Characterization  of  gingipains
The amino acid sequence of proteins used in this study
was obtained from the UniProtKB database14 (http://www.
uniprot.org/). The 3D model of Gingipain R2 was obtained
from crystallographic data available at http://www.pdb.
org,18 with code 1cvr. The remaining models of
gingipains were generated through the program
MODWEB19 (http://modbase.compbio.ucsf.edu/ModWeb20-
html/modweb.html) and recorded in the program of structural
analysis PyMol12 (http://www.PyMol.org/).
Characterization  of  host  substrates
The information on the host substrates was obtained from the
UniProtKB14 and Merops17 database by searching the name
of the protein. For each of the host substrates we  searched
at http://www.pdb.org18 for the crystallographic information
available. In many  cases the available crystallographic struc-
ture was that of the molecule associated to an inhibitor. When
this was the case, MODWEB19 was used to produce the 3D
structure of the host substrate.
Whenever the secondary structure of a protein was nec-
essary the Protein Structure Prediction Server (PSIPRED) was
used. This is a highly accurate method for protein secondary
structure prediction freely available on-line.13
Results
To clarify the molecular details of the cleavage of Secretory
Leukocyte Protease Inhibitor (SLPI) by gingipains, a determina-
tion of the secondary structure of this molecule was done and
is presented in Fig. 1. All arginine (R) residues of the molecule
are in areas of the corresponding to beta sheets and therefore
possible cleavage sites. The analysis of Fig. 1 also reveals that
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Substrate Surface arginines
(Arg)
SLPI
SAQCLRYKKPE
CPGKKRCCPDT
PNPTRR KPGKC
DGQCKRDLKCC
Identified
Cleaveage points
Surface lysines
(Lys)
PTRRKPG KCPVTY
MDGQCKRDLKC
MDMCGKSCVSP
CVSPVKA
Fig. 1 – Secondary structure surrounding the R and K
residues on the surface of SLPI. Arginine residues are
represented in red and lysine residues in blue. Black lines
represent loops and the arrow represents the organization
Substrate Surface lysines
(Lys)
Identified cleaveage
points
ProMMP-1
VDLVQKYKLEKY
QKYLEKYYNLK
KYYNLKNDGRQ
VVEKLKQMQEF
EFFGLKVTGKP
GKVTGKPDAET
DAETLKVMKQP
DAETLKVMKQP
TLKVMKQPRCG
GPQTPKACDSK
KACDSKLTFDA
EVMFFKDRFYM
EVRFFKGNKYW
FFKGNKYWAVQ
Fig. 3 – Secondary structure surrounding the K residues,in beta sheet.
there are 4 lysine (K) residues on SLPI which could be cleavage
sites for gingipain R2.
In Fig. 2 a model of the 3D structure of pro-MMP1 is pre-
sented showing the surface arginine and lysine residues which
may be cleaved by gingipain R and K, respectively. The sec-
ondary structure of pro-MMP1 is presented in Fig. 3 where the
K residue described previously as the cleavage site is marked
in red. In Fig. 4 the location of the cleavage site identiﬁed for
gingipain K in this study (black arrow) is compared with the
cleavage site described in the literature (blues arrow) in Fig. 4.
The sequence of interpain A from Prevotella intermedia,
identiﬁed by A9J7N5, PrtT (P43158) and periodontain (B2RJ74)
from P. gingivalis was compared and is presented in Fig. 5. From
this image  it can be seen that the sequences for the catalytic
site (TGCVATA) of the proteins is very similar.
Discussion
Proteolytic  activity  of  gingipainsSeveral in vitro studies showed the cleavage of many substrates
related to periodontitis by gingipains R1, R2 and K.7,20–25
Fig. 2 – A model of the 3D structure of pro-MMP1, in which
the cleavage point (in purple) for gingipain K is highlighted
and other lysines are marked (blue) on the surface of the
molecule. This three-dimensional model was obtained
from crystallographic data27 and modiﬁed in PyMol.
highlighted in red, on the surface of the pro-MMP-1. The
residue circled in red is where the cut by gingipain is most
probable.
These substrates include complement proteins, kallikrein,
cytokines, ﬁbrinogen and matrix metalloproteases.8 Using
bioinformatics and modeling tools we set to verify if the anal-
ysis of the crystallographic information available for each
66 80
VEKLKQMQEFFGLKVTGKPDAETLKVMKQPRCGVPDVAQFVLTEGNPRWE
Fig. 4 – Representation of a fragment of the primary
sequence of pro-MMP 1 from residue 42 to 92, indicating
the residue where the cleavage by gingipain K occurs (black
arrow) and the usual cleavage point which leads to
activation of pro MMP-1 (red arrow).
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Fig. 5 – Partial alignment of the primary structure of periodontain, PrtT and interpain A, with the Clustal W2,  on the website
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ubstrate supported the “in vitro” digestion results. Many  of the
ost molecules described as being cleaved by gingipains have
ot had their crystallographic structure determined and there-
ore could not be submitted for this analysis. For instance,
mportant host substrates such as Tumor Necrosis Factor alfa
nd protrombin have only had part of their crystallographic
tructure deposited in the PDB database.18 In other cases, the
xisting crystallographic structure is from a non-human ver-
ion of the molecule. This is why we  restricted our study to
wo molecules that are known not to be integral membrane
roteins and for which digestion in vitro had been reported:
ecretory Leukocyte Protease Inhibitor (SLPI) and the pro-
atrix Metalloprotease 1 (pro-MMP1).
LPI
sing puriﬁed gingipain R1 and SLPI, Into et al.11 demon-
trated, by immunoblot, the cleavage of SLPI by gingipain R1,
riginating 3 fragments, one with 12 kDa and two smaller ones
≥6 kDa, <12 kDa).
When the SLPI molecule was analyzed relative to its sur-
ace we found 5 arginine residues in positions 45, 62, 83, 84
nd 113, present in 2 domains of this molecule which repre-
ent potential cleavage sites for gingipain R. This would lead
o the prediction of 6 fragments after digestion by gingipain.
owever, it is known that structures such as helices or beta
heets indicate areas where the cleavage will be less probable
o, we  further considered the secondary structure of SLPI26
Fig. 1).
From Fig. 1 we  conclude that all R residues present on the
urface of SLPI are possible cleavage sites for gingipain R, but
he size of the fragments obtained experimentally11 suggests
hat most likely the cleavage occurs at R residues 62 and 83/84.
n this case the bioinformatics analysis of SLPI structure cor-
oborates the experimental results obtained previously.11A similar analysis of SLPI surface regarding K residues leads
o the conclusion that there are 4 possible cleavage sites for
ingipain K. These putative cleavage sites allow us to pre-
ict that if the cleavage occurs on residue 85, fragments verysimilar to those obtained by the digestion of gingipain R1 (12
and 6 kDa) will be obtained; the cut in residue 99 is not likely
due to the fact that this K is inserted in a beta-sheet and
therefore inaccessible to gingipain K; if the cleavage occurs
at residue 112 two fragments will be originated one over
12 kDa and a smaller one; ﬁnally a cut near the end of the
SLPI molecule is possible on residue 112 originating a much
smaller fragment and a larger one almost the size of the uncut
molecule. Most likely, there will be three fragments originat-
ing from the digestion of SLPI by gingipain K all below 12 kDa.
The literature lacks experimental data for this digestion and
in this case, the bioinformatics tools allow the prediction of
the experimental results.
MMP-1
DeCarlo et al.10 demonstrated the cleavage and consequent
activation of pro-MMP-1 by gingipain K, with SDS-PAGE, West-
ern blot and sequencing of fragments obtained. The cleavage
of pro-MMP-1 occurs at lysine residue 66. We analyzed the
structure of MMP-1 in order to verify if this residue lies at
the surface of the molecule and therefore the structural and
experimental data are in concordance.
The analysis of ProMMP-1 models (Fig. 2) showed that there
are several loops with lysine residues, representing putative
cleavage points for gingipain K. The cleavage site identiﬁed
experimentally by DeCarlo et al.10 is inserted into a helix
(Fig. 3), which surprised us, because cleavage in helices is not
very common. In order to obtain more  data on the secondary
structure of ProMMP-1 we  ran the sequence of amino acids in
PSIPRED program13.
The lysine residue in this representation is in the transition
between a helix and a loop which increases the likelihood of
access of the gingipain active site. In this case, the structural
analysis of the ProMMP-1 molecule does not strongly support
the experimental data available and raises the question of
why are superﬁcial lysine residues not cleaved by gingipain
K? Are there other factors affecting gingipain K speciﬁcity? Is
the structure of ProMMP-1 altered “in vivo”? These and other
t c i r
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suggestions should be targeted in further studies to elucidate
the molecular behavior of gingipain K and enhance the devel-
opment of more  efﬁcient inhibitors.
Comparing the proximity in the cleavage of pro-MMP1 by
gingipain K and the usual cleavage point that leads to its acti-
vation “in vivo”, we  found that these sites are nearby, which
supports the suggestion of DeCarlo et al.10 that the cleavage by
gingipain K leads to the activation of pro-MMP1 (Fig. 4). Other
MMPs  have been described as being activated by gingipains
even though the molecular mechanisms of the cleavage have
not been described in detail.28,29 For example, MMP-9 seems to
be activated by the cleavage of the 92 kDa proMMP-9 zymogen
to the 82 kDa active form by P. gingivalis.30 In another in vitro
study Grayson et al.31 found that latent MMP-2 in the presence
of gingipain R1 was activated.
Proposal  of  proteolitic  activity  by  other  proteases
The effect of microbial proteases on elastase inhibitors seems
to play an important role in the virulence mechanisms associ-
ated with periodontitis. The degradation of alpha 1 antitrypsin
by PrtT and periodontain32 had already been described. These
two cysteine proteases of P. gingivalis are included in C1017
family along with streptopain and interpain A. The fact that
the C10 protease family includes two proteases from P. gin-
givalis and one from another bacteria (P. intermedia)  that is
commonly associated with periodontal disease, led us to
search for the evidence of structural identity between these
proteases making the proposal that, if there is structural
homology, there may be functional similarities.
Interpain A is encoded by the locus PIN0048 and secreted
as a zymogen of 868 aa including a signal peptide of 44 aa, a
pro-domain (Ala1-Asn111), a catalytic domain (Val112-Pro359)
and a C-terminal with possible regulatory and secretory func-
tions; however, their speciﬁc targets and functions are yet
to be clariﬁed.33 The alignment of interpain A sequence and
PrtT and periodontain (Fig. 5) shows great similarities espe-
cially at the active site of the enzymes. Consequently, we
suggest that interpain A, produced by P. intermedia,  also cleaves
alpha 1 antiproteinases, preventing the inhibition of elas-
tases produced by neutrophils. This suggestion supports the
polymicrobial nature of periodontitis, showing virulence fac-
tors of different microorganisms with identical molecular
effects. In fact, Potempa et al.34 have shown the degrada-
tion of complement factor 3 by interpain A from P. intermedia
in vitro which is one of the molecules also degraded by the
gingipains.8
Conclusion
The use of bioinformatics tools such as PyMol, Psired and other
structure analysis tools, coupled with the structural informa-
tion available in several public databases (UniprotKB, MEROPS,
PDB) enabled the veriﬁcation of the molecular detail of in vitro
reactions (gingipains digestion of SLPI and MMP1). The results
of SLPI digestion by gingipain R1 were supported by the struc-
tural analysis, and the activation of MMP1  by gingipain R1
was  partially supported. Predictions of the fragments most
likely to be obtained from the digestion of SLP by gingipain K
are also made. Furthermore, the fact that experimentally less m a x i l o f a c . 2 0 1 2;5  3(4):240–245
fragments are observed than what might be expected from
the theoretical prevision suggests that other factors may be
affecting enzyme speciﬁcity and/or substrate conformation
“in vivo”.
The prediction of new interactions was based on the com-
parison of the structural similarities shared by the members
of the C10 protease family. We  suggest that, based on those
similarities, interpain A (produced by P. intermedia)  cleaves
alfa 1 antitripsin proteinase supporting a synergistic action
with the proteases of P. gingivalis promoting host tissue
destruction.
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